Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

10.3K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.3K
Autoimmune Disorders01:29

Autoimmune Disorders

2.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

198
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
198
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

258
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
258
Humoral Immune Responses01:36

Humoral Immune Responses

65.6K
Overview
65.6K
Antibody Actions01:26

Antibody Actions

3.8K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trimerous magnoliid flowers with a unique set of floral and pollen traits from the Late Cretaceous of Southern Bohemia (Czech Republic).

The New phytologist·2026
Same author

IgA nephropathy-associated breast milk B cell alterations.

Frontiers in immunology·2026
Same author

Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.

RMD open·2026
Same author

Serum steroid metabolome pattern is associated with the response to prednisolone therapy of male patients with IgA nephropathy.

Renal failure·2026
Same author

B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment.

Annals of the rheumatic diseases·2025
Same author

Intercenter Variability in the Application of Biopsy-based Transcriptomics in Kidney Transplantation.

Transplantation direct·2025

Related Experiment Video

Updated: Apr 24, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.6K

Complement system in SLE as a target for antibodies.

Pavel Horak, Martina Skacelova, Josef Zadrazil

  • 1III Department of Internal Medicine, Faculty of Medicine and Dentistry, Palacky University of Olomouc, I.P. Pavlova 6, 772 00 Olomouc, Czech Republic. horakp@fnol.cz.

Current Rheumatology Reviews
|September 9, 2014
PubMed
Summary

Autoantibodies against C1q are common in Systemic Lupus Erythematosus (SLE), often indicating high disease activity and kidney involvement. These anti-C1q antibodies are also found in other conditions.

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.6K
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

29.8K

Related Experiment Videos

Last Updated: Apr 24, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.6K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.6K
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

29.8K

Area of Science:

  • Immunology
  • Rheumatology

Background:

  • Systemic Lupus Erythematosus (SLE) involves autoantibody overproduction.
  • Antibodies targeting neoepitopes of the complement system, particularly anti-C1q, are observed.
  • Anti-C1q antibodies are present in about one-third of SLE patients, correlating with high disease activity and renal involvement.

Purpose of the Study:

  • To investigate the significance of anti-C1q antibodies in SLE.
  • To explore the association of anti-C1q antibodies with complement component levels and clinical manifestations.
  • To determine the specificity of anti-C1q antibodies beyond SLE.

Main Methods:

  • Clinical data and autoantibody levels were assessed in SLE patients.
  • Complement component levels (C1q, C3, C4) were measured.
  • Presence of anti-C1q antibodies was evaluated in various conditions.

Main Results:

  • High titers of anti-C1q antibodies were associated with low levels of C1q, C3, and C4.
  • Anti-C1q antibodies were linked to high clinical disease activity and renal involvement in SLE.
  • Anti-C1q antibodies were also identified in Hypocomplementemic Urticarial Vasculitis Syndrome (HUVS), Felty's syndrome, rheumatoid vasculitis, hepatitis C, poststreptococcal glomerulonephritis, and aging populations.

Conclusions:

  • Anti-C1q antibodies are significant biomarkers in SLE, particularly for disease activity and renal prognosis.
  • The presence of anti-C1q antibodies is not exclusive to SLE, suggesting broader implications in autoimmune and inflammatory conditions.